Clinical Trials
599 trialsDCP-NDM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
H. Lee Moffitt Cancer Center and Research Institute
Multicentric Database for KRAS Mutant Pancreatic Cancer
Fudan University
DCP-DM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
LEARN
University of Sydney
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Imperial College London
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
K4CARE-PDAC
Chang Gung Memorial Hospital
VAPOR
Imperial College London
KITuKo
Medizinische Hochschule Brandenburg Theodor Fontane
PSR for SPN
Fudan University
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
M.D. Anderson Cancer Center
PREDIPER
Assistance Publique - Hôpitaux de Paris
Pancreatic Cancer Genetics
Columbia University
iCaRe2
University of Nebraska
PREDICT-PANC
Medical College of Wisconsin
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
Shanghai Zhongshan Hospital
MRinRT
Swansea Bay University Health Board
Map HPB
University of Nottingham
PATAKESS
Centre Leon Berard
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
West Virginia University
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
Ruijin Hospital
Predicting Effective Therapy in Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
MiPac
St. Antonius Hospital
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SJFAMILY
St. Jude Children's Research Hospital
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mayo Clinic
PRECEDE
Arbor Research Collaborative for Health
PRONPaC
Medizinische Hochschule Brandenburg Theodor Fontane
CONVERCAP
Institut Bergonié
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
University of Maryland, Baltimore
MIND-PANC
Shanghai Zhongshan Hospital
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Nuvance Health
PANDOME
Nuvance Health
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
UroPanc
Queen Mary University of London
Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Columbia University
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
University of Oklahoma
RAFPAN2
GCS Ramsay Santé pour l'Enseignement et la Recherche
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Dana-Farber Cancer Institute
PAN-Plastic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SAIC-PBTC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
(CLOCS-2)
Imperial College London
(FACET)
Baylor College of Medicine
Evaluation of Resection Techniques for Pancreatic Tumors
Methodist Health System
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Mayo Clinic